Sergliflozin etabonate
Sergliflozin etabonate (KGT-1251) is a selective SGLT2 inhibitor for research on type 2 diabetes and obesity. It has demonstrated efficacy in reducing hyperglycemia and body weight in rodent models, making it a tool for in vivo metabolic studies.
Product Specifications
CAS Number
408504-26-7
Product Name Alternative
KGT 1251, GW 869682, GW 869682X, GW869682, GW869682X, GW-869682X, SGLT2, Sergliflozin etabonate
Field of Research
Pharmacology & Drug Discovery
Purity
95.59% (May vary between batches)
Solubility
DMSO:50 mg/mL (111.49 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (11.15 mM)
Smiles
O (C1=C (CC2=CC=C (OC) C=C2) C=CC=C1) [C@@H]3O[C@H] (COC (OCC) =O) [C@@H] (O) [C@H] (O) [C@H]3O
Molecular Formula
C23H28O9
Molecular Weight
448.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2414-20G 100 Tests
CD61 (ITGB3, Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61), GP3A, GPIIIa, Integrin beta-3, Platelet membrane glycoprotein IIIa) (PE) discontinued
Sign In for Pricing
View Details 
bsm-42327M-BF555 100 µL
E.coli BirA Monoclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details 
RPC20789-01 20 µg
Recombinant Lymphocytic choriomeningitis virus Pre-glycoprotein polyprotein GP complex (GPC) ,partial
Sign In for Pricing
View Details